Skip to main content
Equibles
UNH logo

UNH · Unitedhealth Group Inc

Track UNH — free

Use UNH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UNH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$376.88 -0.02 (-0.01%)
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$338.30B
Shares
897.59M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$376.90 Open$375.29 Day$372.42–378.49 52W close$259.02–436.35 Avg vol 30d4.6M Short int15.3M · 1.7% float · 3.6d Short vol42% Last earningsJul 16, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Oct 13, 2026 Est · unconfirmed · in 3 wks
Latest filing: 10-Q
filed Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+12.6%
Trailing year
Short interest
1.7%
Latest settlement · 3.6 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Strong Sentiment Neutral Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg +6%
above
Price vs 50-day avg −7%
below
RSI (14) 37
neutral
MACD trend Negative
52-week position 66%
mid-range
Momentum
relative strength
Strong
1-month return −2%
trailing
6-month return +46%
trailing
YTD return +14%
this year
Relative strength +25%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $404 › 200d $354 — 50d above 200d
Institutional flow Accumulating
+10% holders QoQ · +523 funds added
Insider flow Distributing
Net -$660.9K over 90 days · 100% sells
Short interest Falling
1.70% of float · ▼ -1.1% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3,384 holders — mid 3-yr range
Squeeze score 45
elevated · 0–100
Fundamentals
Fair
Revenue growth +12%
Y/Y
EPS growth −15%
Y/Y
Free cash flow $16.1B
Balance sheet $54.0B
net debt
Quant / Vol
risk profile
Moderate
Volatility 34%
annualized · 1-yr
Max drawdown −30%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the 8-K filed Jul 16, 2026
Full Year 2026
Medical Care Ratio Initiated 88.1%
Tax Rate Initiated 18.5%
Adjusted Earnings per Share Initiated $19.50 – $20.00
Projected Year Ended December 31, 2026
Diluted earnings per share Initiated $18.45 – $18.95
prior FY $13.23 midpoint +41.3% Y/Y
Diluted earnings per share Initiated $18.45 – $18.95
Adjusted diluted earnings per share Initiated $19.50 – $20.00
Prior guidance period ended · from the 8-K filed Jul 16, 2024
Net earnings outlook · full year 2024 $15.95 – $16.40
Adjusted net earnings outlook · full year 2024 $27.50 – $28.00
Total full year 2024 impact · full year 2024 $1.90 – $2.05
Direct response costs · full year 2024 $1.30 – $1.35
Business disruption impacts · full year 2024 $0.60 – $0.70
Guided vs delivered · last 2 settled
Net earnings outlook full year 2024
guided $15.95 – $16.40
$15.51 Miss −4.1%
Total revenue 2021
guided $280B
$287.6B Beat +2.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+6% Bullish
Price vs 50-day avg
−7% Bearish
RSI (14)
37 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $404 › 200d $354 — 50d above 200d
Institutional flow Accumulating
+10% holders QoQ · +523 funds added
Insider flow Distributing
Net -$660.9K over 90 days · 100% sells
Short interest Falling
1.70% of float · ▼ -1.1% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
3,384 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $259 Now $377 · 66% Range high $436
vs 200-day avg +6% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Healthcare Plans — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
UNH
Unitedhealth Group Inc
this stock
$338.30B +14.2% +11.8% — 1.7%
CVS
CVS HEALTH Corp
 $118.77B +11.9% +7.8% 24.5 1.4%
ELV
Elevance Health, Inc.
 $90.52B +17.2% +12.5% 18.5 2.5%
CI
Cigna Group
 $75.22B +0.0% +11.2% 11.8 2.4%
HUM
Humana Inc
 $46.17B +50.8% +10.1% 41.0 2.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
3,384
% held
95.2%
Net QoQ
+17.2M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
1,651
View
Short & Settlement
Short Interest Falling
Shares short
15.3M
Days to cover
3.6d
Change
-174.6K sh
View
Short Volume
Short vol %
42%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
79
Value
$31.3K
As of
Aug 26, 2026
View
Off-Exchange
Off-exchange %
44.8%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$660.9K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Richard Dean McCormick
Amount
$1.0K–$15.0K
Traded
Jul 30, 2026
View
Financials
Financials
Revenue (FY)
$447.6B
Net income (FY)
$12.1B
EPS diluted
$13.23
View
Buybacks
Authorized
shares 35.0M
Remaining
shares 21.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 8, 2026
This year
14
View
Proposed Sales
Value
$455.9K
Shares
1.2K
Filed
Aug 21, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 16, 2026
View

Performance

5D 20D 120D MTD YTD
UNH -0.6% -2.1% +45.5% -3.2% +14.2%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY -0.2% -2.0% +25.4% -2.5% +2.5%

Capital returns

Buyback program · as of Dec 31, 2025
Authorized
shares 35.00M
Spent (derived)
shares 14.00M
Remaining
shares 21.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 731766 CUSIP 91324P102 13F (30d) 92 filings 44 filers Visit website Investor relations